Fingerprint
Dive into the research topics of 'Risk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Edward V. Loftus, Scott J. Johnson, Si Tien Wang, Eric Wu, Parvez M. Mulani, Jingdong Chao
Research output: Contribution to journal › Article › peer-review